↓ Skip to main content

Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

Overview of attention for article published in Trials, May 2021
Altmetric Badge

Mentioned by

twitter
7 X users

Readers on

mendeley
303 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial
Published in
Trials, May 2021
DOI 10.1186/s13063-021-05181-0
Pubmed ID
Authors

Verena Keitel, Björn Jensen, Torsten Feldt, Johannes C. Fischer, Johannes G. Bode, Christiane Matuschek, Edwin Bölke, Wilfried Budach, Christian Plettenberg, Kathrin Scheckenbach, Detlef Kindgen-Milles, Jörg Timm, Lisa Müller, Henrike Kolbe, Andreas Stöhr, Christian Calles, Andreas Hippe, Pablo Verde, Christoph D. Spinner, Jochen Schneider, Timo Wolf, Winfried V. Kern, Jacob Nattermann, Alexander Zoufaly, Christian Ohmann, Tom Luedde

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 303 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 303 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 35 12%
Student > Master 33 11%
Student > Ph. D. Student 22 7%
Researcher 17 6%
Lecturer 9 3%
Other 39 13%
Unknown 148 49%
Readers by discipline Count As %
Medicine and Dentistry 60 20%
Nursing and Health Professions 34 11%
Psychology 15 5%
Social Sciences 5 2%
Pharmacology, Toxicology and Pharmaceutical Science 4 1%
Other 22 7%
Unknown 163 54%